Recursion Pharmaceuticals: 18% rebound, but moving averages push back

Week 4 of the sell signal on Recursion Pharmaceuticals, and this week the stock closed up 2.5% — a pause after declines of 7.7% and 5% in the prior 2 weeks. The daily chart shows a double bottom in the 2.8 area with an 18% recovery from the lows. The quality band flags trading as not recommended, and the cluster of moving averages in the 3.3 area has repeatedly rejected every recovery attempt.